Perspective - Research and Reports on Genetics (2024) Volume 6, Issue 2
Unveiling the Hidden Regulators: The Emerging Role of Noncoding RNA
Balint Nagy *
Department of Human Genetics, University of Debrecen, Hungary.
- *Corresponding Author:
- Balint Nagy
Department of Human Genetics
University of Debrecen,
University of Debrecen
E-mail:shikha.suman27@gmail.com
Received:27-Feb-2024,Manuscript No. AARRGS-24-129250; Editor assigned:01-Mar-2024,PreQC No. AARRGS-24-129250(PQ); Reviewed:12-Mar-2024,QC No. AARRGS-24-129250; Revised:18-Mar-2024, Manuscript No. AARRGS-24-129250(R); Published:26-Mar-2024,DOI:10.35841/aarrgs-6.2.195
Citation: Nagy B. Unveiling the hidden regulators: The emerging role of noncoding RNA. J Res Rep Genet.2024;6(2):195
Introduction
In the intricate symphony of molecular biology, noncoding RNA (ncRNA) is emerging as a crucial player, challenging the traditional view of genetic information solely encoded in DNA and expressed through messenger RNA (mRNA). Once considered junk or dark matter of the genome, noncoding RNAs are now recognized as essential regulators of gene expression, genome stability, and cellular processes. This article delves into the fascinating world of noncoding RNA, exploring its diverse functions, mechanisms of action, and its potential as a therapeutic target.[1,2].
Noncoding RNA encompasses a broad spectrum of RNA molecules that do not code for proteins. This diverse category includes transfer RNA (tRNA), ribosomal RNA (rRNA), small nuclear RNA (snRNA), small nucleolar RNA (snoRNA), microRNA (miRNA), long noncoding RNA (lncRNA), circular RNA (circRNA), and more recently discovered classes such as piwi-interacting RNA (piRNA) and enhancer RNA (eRNA). Each subtype exhibits unique features and functions within the cellular milieu.Noncoding RNAs exert their regulatory roles through various mechanisms.[3,4].
MicroRNAs, for instance, bind to complementary sequences in target mRNA molecules, leading to translational repression or mRNA degradation. Long noncoding RNAs can modulate gene expression through diverse mechanisms, including chromatin remodeling, transcriptional regulation, and post-transcriptional processing. Additionally, noncoding RNAs participate in RNA splicing, RNA editing, and epigenetic modifications, contributing to the dynamic regulation of gene expression networks.[5,6].
Noncoding RNAs play pivotal roles in numerous biological processes, ranging from embryonic development and cellular differentiation to immune response and disease pathogenesis. MicroRNAs, with their ability to fine-tune gene expression, regulate fundamental cellular processes such as proliferation, apoptosis, and metabolism. Long noncoding RNAs act as scaffolds, guides, or decoys, orchestrating gene expression programs and contributing to tissue homeostasis and development. Dysregulation of noncoding RNAs has been implicated in various diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases, highlighting their diagnostic and therapeutic potential 7,8].
The unique properties of noncoding RNAs make them promising targets for therapeutic intervention. MicroRNAs, for instance, can be manipulated using antisense oligonucleotides or small molecule inhibitors to restore normal gene expression patterns in diseased cells. Long noncoding RNAs offer potential therapeutic targets for conditions where their dysregulation contributes to pathogenesis. Furthermore, noncoding RNAs hold promise as diagnostic biomarkers, offering insights into disease prognosis and treatment response.Despite the growing appreciation of noncoding RNAs, numerous challenges remain in their study and therapeutic exploitation. Deciphering the complex regulatory networks orchestrated by noncoding RNAs requires advanced experimental techniques and computational analyses. Additionally, the delivery of RNA-based therapeutics faces hurdles such as stability, specificity, and off-target effects. Future research efforts aim to overcome these challenges, unraveling the full potential of noncoding RNAs in health and disease.[9,10].
Conclusion
Noncoding RNAs represent a fascinating frontier in molecular biology, challenging conventional notions of genetic regulation and function. From their diverse roles in gene expression to their potential as therapeutic targets, noncoding RNAs offer exciting opportunities for scientific discovery and medical innovation. As research continues to unveil the mysteries of these hidden regulators, the era of noncoding RNA biology promises to revolutionize our understanding of biology and transform clinical practice.
References
- Amaral PP, Mattick JS. Noncoding RNA in development. Mam Gen. 2008;19:454-92.
- Bhan A. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965-81.
- Laurent GS. The Landscape of long noncoding RNA classification. Gene. 2015;31(5):239-51
- Mattick JS. The functional genomics of noncoding RNA. Sci. 2005;309(5740):1527-8.
- Cech TR, Steitz JA. The noncoding RNA revolution—trashing old rules to forge new ones. Cell. 2014 ;157(1):77-94.
- Hung T, Chang HY. Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Bio. 2010;7(5):582-5.
- Ponting CP. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629-41.
- Schmitz SU. Mechanisms of long noncoding RNA function in development and disease. Life Sci. 2016;73:2491-509.
- Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Ann Rev Bio Chem. 2012 ;81:145-66.
- Kung JT. Long noncoding RNAs: past, present, and future. Gene. 2013;193(3):651-69.
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref.
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref